3- and 5-[3-(1-arylureido)]-1,2,4-triazoles

Details 3- and 5-[3-(1-arylureido)]-1,2,4-triazoles 3- and 5-[3-(1-arylureido)]-1,2,4-triazoles

1986-07-11

1989-12-05

Ford, John M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514384, 514218, 514252, 514376, 514377, 514374, 514369, 514370, 514371, 514365, 514316, 514318, 514326, 514333, 514336, 514340, 514341, 514342, 514269, 514275, 514256, 514272, 514274, 514273, 5142278, 5142318, 5142362, 540575, 548265, 548268, 548233, 548235, 548236, 548234, 548232, 548230, 548229, 548228, 548227, 548226, 548225, 548194, 548183, 548195, 548184, 548185, 548196, 548187, 548188, 548190, 548191, 548192, 548266, 548267, 548264, 544357, 544360, 544364, 544369, 544370, 544371, 544366, 544365, 54429

Patent

active

RE0331252

ABSTRACT:
##STR1## This invention relates to [1-aryl-4-hydrazinyl-1,2-dihydro-1,3,5-triazin-2-ones and 2-thiones] 3- and 5-[3-(1-arylureido)] -1,2,4-triazoles and 3- and 5-[3-(1-(arylthioureido.Iadde nd.)]-triazoles of Formula I, processes for their preparation, isobiuret and 4-alkoxy-s-triazinone preparative intermediates, and methods of treating physiological disorders in humans and animals, in particular, cardiovascular disorders, including hypertension.

REFERENCES:
patent: 3144460 (1964-08-01), Hosler et al.
patent: 4246409 (1981-01-01), Douglas et al.
patent: 4338441 (1982-07-01), Douglas et al.
patent: 4406897 (1983-09-01), Campbell et al.

Affiliated with

Also associated with

Rating

3- and 5-[3-(1-arylureido)]-1,2,4-triazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3- and 5-[3-(1-arylureido)]-1,2,4-triazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3- and 5-[3-(1-arylureido)]-1,2,4-triazoles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2026231